Driving innovation to improve cancer outcomes, reduce inequalities and transform care across the East of England.
Innovation is central to improving cancer outcomes, experience and access to care across the East of England.
The East of England Cancer Alliance works with clinicians, patients, researchers, innovators, healthcare organisations and industry partners to identify, evaluate and support the adoption of innovations that can improve the prevention, diagnosis, treatment and long-term management of cancer.
Innovation plays a key role in delivering the ambitions of the East of England Cancer Alliance Strategy, the National Cancer Plan for England and the NHS 10 Year Health Plan. Through innovation, we aim to support earlier diagnosis, reduce inequalities, improve patient outcomes and experience, increase productivity and contribute to the delivery of sustainable cancer services for the future.
We work closely with regional and national partners, including Health Innovation East, the National Institute for Health and Care Research (NIHR) Research Delivery Network East of England, universities, NHS organisations and industry partners, to support the development, evaluation and spread of promising innovations.
This collaborative approach helps ensure that patients across the region can benefit from emerging technologies, evidence-based innovations and new models of care. It also enables organisations to share learning, develop best practice and contribute to innovation at a national level.
Innovation and digital technologies have the potential to transform cancer care by supporting earlier and more accurate diagnosis, improving access to services, reducing waiting times, enhancing patient experience and enabling more personalised approaches to care. Many innovations developed within cancer pathways also have wider applications across health and care, creating opportunities for broader system improvement.
The Cancer Alliance has supported the adoption and evaluation of a range of innovative approaches across the region, including technologies that support earlier diagnosis, pathway transformation and improved patient outcomes. Examples include capsule sponge technologies and colon capsule endoscopy for upper and lower gastrointestinal pathways, digital innovations to support lung cancer screening, and teledermatology services to improve access to skin cancer assessment.
Further information about our innovation programmes, projects and partnerships is available through the pages below.